Drug Development Archives - Oncology Central Oncology Central

i
i

19 May 2020 Brain and neurologic
Novel immunotherapy combination shows promise for pediatric medulloblastoma in mice
15 May 2020 Skin
Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma
6 Apr 2020 Immuno-oncology
Neoadjuvant immunotherapy could improve survival in colon cancer
16 Mar 2020 Drug development
Novel platinum chemotherapy in development with promising preclinical results
28 Feb 2020 News
Combination therapy could boost efficacy for endometrial, colorectal and gastric tumors
25 Feb 2020 Lung
Leukemia drugs could be used against treatment-resistant lung cancer
17 Feb 2020 Videos
Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices
10 Feb 2020 Opinion
Overcoming resistance to CAR-T therapy: an interview with Saad Kenderian
29 Jan 2020 News
Cancer patients are waiting longer for the most innovative treatments to reach the clinic
27 Jan 2020 Journal Articles
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study
21 Jan 2020 Immuno-oncology
Newfound killer T cell could target most cancers
21 Jan 2020 Preclinical research and trials
Old drugs, new tricks: several non-oncology drugs can kill cancer cells